[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351563-105":59,"doc-detail-351563-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-novel-partial-emt-associated-transcriptomic-signature-for-prognostic-stratification-in-ovarian-cancer","A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer","","Partial epithelial–mesenchymal transition (p-EMT) is a dynamic cellular state linked to metastasis and poor outcomes in many cancers, yet its prognostic relevance in ovarian cancer is unclear. The study develops and validates an ovarian cancer–specific transcriptomic signature based on p-EMT–related genes. Using TCGA-OV data, a six-gene LASSO-derived risk score is integrated with clinical factors to form a prognostic nomogram, then tested in external GEO cohorts for survival prediction performance.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-partial-emt-associated-transcriptomic-signature-for-prognostic-stratification-in-ovarian-cancer/351563/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-partial-emt-associated-transcriptomic-signature-for-prognostic-stratification-in-ovarian-cancer/351563.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of the study on partial EMT in ovarian cancer?","Question",{"text":113,"@type":114},"To develop and validate an ovarian cancer–specific transcriptomic signature using p-EMT–related genes, and to test whether it improves prognostic stratification and overall survival prediction across independent cohorts.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the transcriptomic signature constructed and evaluated?",{"text":118,"@type":114},"A pan-cancer p-EMT gene set was curated, and transcriptomic plus clinical data from TCGA-OV were used to develop a six-gene signature via LASSO regression to generate patient-specific risk scores, then integrated with clinical variables for a nomogram.",{"name":120,"@type":111,"acceptedAnswer":121},"Which cohorts were used for external validation and what was the outcome?",{"text":122,"@type":114},"External validation used GEO cohorts GSE140082 and GSE165808, confirming robustness and preserved prognostic value through reported AUC performance for survival prediction.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351563,1790387426,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Tech Science Press  \n[https://doi. org/10.32604/or.2026.074383](https://doi. org/10.32604/or.2026.074383)  \nARTICLE  \nA Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer  \nChia-Chia Chao1, Cheng-Yao Lin2,3,4, Po-Chun Chen5,6,7, Wen-Tsung Huang2, Teng-Song Weng8 and Sheng-Yen Hsiao2,9, *  \n1 Department of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, Taiwan  \n2 Division of Hematology-Oncology, Department of Internal Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan 3 Department of Senior Welfare and Services, Southern Taiwan University of Science and Technology, Tainan, Taiwan 4 Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan 5 School of Life Science, National Taiwan Normal University, Taipei, Taiwan  \n6 Translational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan  \n7 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan 8 Department of Pharmacy, Chi Mei Medical Center, Liouying, Tainan, Taiwan  \n9 Department of Nursing, Chung Hwa University of Medical Technology, Tainan, Taiwan  \n*Corresponding Author: Sheng-Yen Hsiao. Email: [a60251@mail.chimei.org.tw](a60251@mail.chimei.org.tw)[ ](a60251@mail.chimei.org.tw)Received: 10 October 2025; Accepted: 29 January 2026; Published: 22 April 2026  \nABSTRACT: Background: Partial epithelial–mesenchymal transition (p-EMT) is a dynamic cellular state associated with metastasis and adverse outcomes in multiple cancers, but its prognostic significance in ovarian cancer remains unclear. This study aimed to develop and validate an ovarian cancer–specific transcriptomic signature based on p-EMT–related genes, and to determine whether this signature can improve prognostic stratification and overall survival prediction across independent cohorts. Methods: A pan-cancer p-EMT gene set was curated from ten published studies. Using transcriptomic and clinical data from TCGA-OV (n = 488), a six-gene p-EMT signature was developed via LASSO regression to generate a patient-specific risk score. The score was integrated with clinical variables to construct a prognostic nomogram and validated in the external GEO cohort GSE140082 (n = 380) and GSE165808 (n = 51) . Results: A six-gene p-EMT transcriptomic signature (ADAM9, ANXA8L1, FSTL3, RABAC1, TPM4, and TWIST1) was significantly associated with overall survival (OS) and stratified patients into high- and low-risk groups (adjusted HR = 1.74, p \u003C 0.001) . Incorporation with age and FIGO stage in a nomogram improved predictive performance, with AUCs of 0.727, 0.700, and 0.656 at 1-, 3-, and 5-year OS, respectively. External validation in GSE140082 and GSE165808 confirmed model robustness, yielding 3-year AUCs of 0.630 and 0.826, respectively, demonstrating preserved prognostic value across independent cohorts and disease stages. Conclusions: This six-gene p-EMT transcriptomic signature demonstrates prognostic value in ovarian cancer and offers potential for individualized risk stratification and clinical decision support.  \nKEYWORDS: Partial epithelial-mesenchymal transition; ovarian cancer; prognosis; transcriptomic risk score; partial epithelial–mesenchymal transition (p-EMT) signature  \n1 Introduction  \nOvarian cancer ranks as the eighth most common malignancy in women, contributing to 3.4% of new cancer diagnoses and 4.8% of female cancer-related deaths worldwide in 2022 [1] . Although global survival has gradually improved [2], outcomes for patients presenting with advanced-stage disease remain  \nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \npoor, underscoring the need for improved tools for early dete","cbCaie9QKSLnESPy","https://ap.wps.com/l/cbCaie9QKSLnESPy","pdf",3029857,15,"English","# Abstract\n# Introduction\n## Background on p-EMT and EMT\n## Need for ovarian cancer prognostic tools\n# Methods and Validation\n## Development from TCGA-OV\n## External validation in GEO cohorts","[{\"question\":\"What is the purpose of the study on partial EMT in ovarian cancer?\",\"answer\":\"To develop and validate an ovarian cancer–specific transcriptomic signature using p-EMT–related genes, and to test whether it improves prognostic stratification and overall survival prediction across independent cohorts.\"},{\"question\":\"How was the transcriptomic signature constructed and evaluated?\",\"answer\":\"A pan-cancer p-EMT gene set was curated, and transcriptomic plus clinical data from TCGA-OV were used to develop a six-gene signature via LASSO regression to generate patient-specific risk scores, then integrated with clinical variables for a nomogram.\"},{\"question\":\"Which cohorts were used for external validation and what was the outcome?\",\"answer\":\"External validation used GEO cohorts GSE140082 and GSE165808, confirming robustness and preserved prognostic value through reported AUC performance for survival prediction.\"}]","A Novel Partial EMT-Associated Transcriptomic Signature for Prognostic Stratification in Ovarian Cancer | PDF",1790094727,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb420cbb1e5419ff2a14c336feedf3c7.webp",983,1271,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63abc0d5eec245ee5557264a762a0faf.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47904f155da4ba8955993bb2417fe9b9.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5921c73d9e26a35b7bcf0958060a0cc0.webp",980,1267]